|
1
|
Domenighetti AA, Wang Q, Egger M, Richards
SM, Pedrazzini T and Delbridge LM: Angiotensin II-mediated
phenotypic cardiomyocyte remodeling leads to age-dependent cardiac
dysfunction and failure. Hypertension. 46:426–432. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mazzolai L, Pedrazzini T, Nicoud F,
Gabbiani G, Brunner HR and Nussberger J: Increased cardiac
angiotensin II levels induce right and left ventricular hypertrophy
in normotensive mice. Hypertension. 35:985–991. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Domenighetti AA, Ritchie M, Smyth G,
Pedrazzini T, Proietto J and Delbridge LMD: Gene expression
profiling reveals distinct sets of genes altered during hormonally
and metabolically induced cardiac hypertrophies. J Mol Cell
Cardiol. 37:3032004.
|
|
4
|
Ferreira AJ, Murça TM, Fraga-Silva RA,
Castro CH, Raizada MK and Santos RA: New cardiovascular and
pulmonary therapeutic strategies based on the
Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor
axis. Int J Hypertens. 2012:1478252012.PubMed/NCBI
|
|
5
|
Raizada MK and Ferreira AJ: ACE2: a new
target for cardiovascular disease therapeutics. J Cardiovasc
Pharmacol. 50:112–119. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vickers C, Hales P, Kaushik V, et al:
Hydrolysis of biological peptides by human angiotensin-converting
enzyme-related carboxypeptidase. J Biol Chem. 277:14838–14843.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Der Sarkissian S, Huentelman MJ, Stewart
J, Katovich MJ and Raizada MK: ACE2: a novel therapeutic target for
cardiovascular diseases. Prog Biophys Mol Biol. 91:163–198.
2006.PubMed/NCBI
|
|
8
|
Rice GI, Thomas DA, Grant PJ, Turner AJ
and Hooper NM: Evaluation of angiotensin-converting enzyme (ACE),
its homologue ACE2 and neprilysin in angiotensin peptide
metabolism. Biochem J. 383:45–51. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stanziola L, Greene LJ and Santos RA:
Effect of chronic angiotensin converting enzyme inhibition on
angiotensin I and bradykinin metabolism in rats. Am J Hypertens.
12:1021–1029. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gomes ER, Santos RA and Guatimosim S:
Angiotensin-(1-7)- mediated signaling in cardiomyocytes. Int J
Hypertens. 2012:4931292012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferreira AJ and Santos RA: Cardiovascular
actions of angiotensin-(1-7). Braz J Med Biol Res. 38:499–507.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang T, Li Z, Dang H, et al: Inhibition
of Mas G-protein signaling improves coronary blood flow, reduces
myocardial infarct size, and provides long-term cardioprotection.
Am J Physiol Heart Circ Physiol. 302:H299–H311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vignon-Zellweger N, Heiden S, Miyauchi T
and Emoto N: Endothelin and endothelin receptors in the renal and
cardiovascular systems. Life Sci. 91:490–500. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shichiri M, Hirata Y, Ando K, et al:
Plasma endothelin levels in hypertension and chronic renal failure.
Hypertension. 15:493–496. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei CM, Lerman A, Rodeheffer RJ, et al:
Endothelin in human congestive heart failure. Circulation.
89:1580–1586. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yazici M, Demircan S, Durna K and Sahin M:
The relation between endothelin-1 levels and myocardial injury in
chronic ischemic heart failure. Heart Vessels. 20:95–99. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gironacci MM, Adamo HP, Corradi G, Santos
RA, Ortiz P and Carretero OA: Angiotensin (1-7) induces MAS
receptor internalization. Hypertension. 58:176–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Windischhofer W, Zach D, Fauler G,
Raspotnig G, Köfeler H and Leis HJ: Involvement of Rho and p38 MAPK
in endothelin-1-induced expression of PGHS-2 mRNA in
osteoblast-like cells. J Bone Miner Res. 17:1774–1784. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ohmae M: Endothelin-1 levels in chronic
congestive heart failure. Wien Klin Wochenschr. 123:714–717. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gallagher PE, Ferrario CM and Tallant EA:
Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J
Physiol Heart Circ Physiol. 295:H2373–H2379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Jonge HW, Dekkers DH, Houtsmuller AB,
Sharma HS and Lamers JM: Differential signaling and hypertrophic
responses in cyclically stretched vs endothelin-1 stimulated
neonatal rat cardiomyocytes. Cell Biochem Biophys. 47:21–32.
2007.PubMed/NCBI
|
|
22
|
Santos RA, Ferreira AJ, Verano-Braga T and
Bader M: Angiotensin-converting enzyme 2, angiotensin-(1-7) and
Mas: new players of the renin angiotensin system. J Endocrinol.
216:R1–R17. 2013. View Article : Google Scholar : PubMed/NCBI
|
